Genetic variability and the risk of myocardial infarction in poles under 45 years of age

Archives of Medical Science

Volumn 6, Issue 2, 2010, Pages 160-167

  Sakowicz, Agata ^a   Fendler, Wojciech ^a   Lelonek, Malgorzata ^a   Pietrucha, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Atherosclerosis; Coronary artery disease; Gene polymorphism

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; STROMELYSIN;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

EID: 77951943364     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13887     Document Type: Article

References (54)

1. Żebrowski MR, Kierus A, Żebrowska A. Zawał serca jako proces immunologiczny [Polish]. Forum Kardiologów 2000; 4: 113-116
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
3. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002; 30: 210-214
4. Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun 2006; 20: 113-119 (Pubitemid 43202075)
5. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006; 69: 36-45. (Pubitemid 41814809)
6. Wysocki H. Miażdżyca - etiopatogeneza, aktualne zasady prewencji i terapii. Przew Lek 2004; 7: 80-88
7. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction in the young. The University of Michigan experience. Am Heart J 2002; 143: 56-62.
8. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002; 252: 247-254
9. Marenberg E, Neil R, Lisa FB, Birgitta F, de Ulf F. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-1046 (Pubitemid 24106561)
10. Wienke A, Holm NV, Skytthe A, Yashin AI. The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. Twin Res 2001; 4: 266-274 (Pubitemid 34151419)
11. Zhou X, Huang J, Chen J, Su S, Chen R, Gu D. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemost 2004; 92: 867-873
12. Rdzanek A, Kochman J, Pietrasik A, Wilczynska J, Rancic M, Opolski G. The prevalence of potentially unstable coronary lesions in patients with coronary artery disease - virtual histology study. Kardiol Pol 2008; 66: 244-250
13. Thim T, Hagensen MK, Bentzon JF, Falk E. From vulnerable plaque to atherothrombosis. J Intern Med 2008; 263: 506-516
14. Yokoyama H, Tahara H, Emoto M, et al. The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes. Metabolism 2005; 54: 381-386 (Pubitemid 40250099)
15. Yoshida M, Takano Y, Sasaoka T, Izumi T, Kimura A. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Arterioscler Thromb Vasc Biol 2003; 23: 783-788 (Pubitemid 36566166)
16. Jiang H, Klein RM, Niederacher D, et al. C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction. Int J Cardiol 2002; 84: 171-177 (Pubitemid 34804488)
17. Wenzel K. Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations. Biol Chem 1999; 380: 661-667 (Pubitemid 29322356)
18. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303: 247-250 (Pubitemid 36338232)
19. Hattori H, Sonoda A, Sato H, et al. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res 2006; 1121: 246-249 (Pubitemid 44708883)
20. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002; 33: 2408-2412
21. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003; 92: 1254-1261 (Pubitemid 36723654)
22. Nikkari ST, O'Brien KD, Ferguson M, et al. Intersitial collagenase (MMP-1) expression in human carotid Atherosclerosis. Circulation 1995; 92: 1393-1398
23. Pearce E, Tregouet DA, Samnegard A, et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005; 97: 1070-1076 (Pubitemid 41668921)
24. Martin TN, Penney DE, Smith JA, Groenning BA, Dargie HJ, Hillis GS. Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction. Am J Cardiol 2004; 94: 1044-1046
25. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006; 69: 636-645 (Pubitemid 43139726)
26. Liu PY, Chen JH, Li YH, Wu HL, Shi GY. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost 2003; 90: 132-139
27. Terashima M, Akita H, Kanazawa K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999; 99: 2717-2719 (Pubitemid 29250015)
28. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical pracice. Eur Heart J 2003; 24: 1601-1610 (Pubitemid 37464640)
29. World Health Organizations, International Society of Hypertension Writin Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992
30. Ye SQ, Usher D, Virgil D, Zhang LQ, Yochim SE, Gupta R. A PstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene - a risk factor for coronary artery disease. J Biomed Sci 1999; 6: 18-21. (Pubitemid 29074706)
31. Trabetti E, Biscuola M, Cavallari U, et al. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 2006; 14: 127-130 (Pubitemid 43019094)
32. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 2000; 19: 175-177 (Pubitemid 30332441)
33. Agostino G, Corradino M, Concetta I, et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000; 20: 1600.
34. Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Homer-Vanniasinkam S. Atherosclerosis and the lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 2006; 16: 60-64 (Pubitemid 43214528)
35. Masayuki Yoshida YTTSTIAK. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions dunder flow conditions. Atheroscler Thromb Vasc Biol 2003; 23: 783-788
36. Jilma B, Marsik C, Kovar F, Wagner OF, Jilma-Stohlawetz P, Endler G. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood 2005; 105: 2380-2383 (Pubitemid 40387034)
37. Li Y, Wei YS, Wang M, Zhang PA, Jiang XJ, Huang CX. Association between the Ser128Arg variant of the E-selectin and risk of coronary artery disease in the central China. Int J Cardiol 2005; 103: 33-36 (Pubitemid 41074601)
38. Killestein J, Schrijver HM, Crusius JB, et al. Intracellular adhesion molecule-1 polymorphisms and genetic susceptibility to multiple sclerosis: additional data and meta-analysis 122. Ann Neurol 2000; 47: 277-279 (Pubitemid 30078584)
39. Mycko MP, Kwinkowski M, Tronczynska E, Szymanska B, Selmaj KW. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 1998; 44: 70-75 (Pubitemid 28323656)
40. Flex A, Gaetani E, Angelini F, et al. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med 2007; 262: 124-130 (Pubitemid 47000627)
41. Kretowski A, Wawrusiewicz N, Mironczuk K, et al. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. J Clin Endocrinol Metabol 2003; 88: 4945-4949 (Pubitemid 37357548)
42. Sarecka-Hujar B, Zak I, Krauze J. Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease. Kardiol Pol 2008; 66: 1269-1277
43. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 2008; 409: 349-355 (Pubitemid 351184953)
44. Chen XP, Zhang TT, Du GH. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc Drug Rev 2007; 25: 146-161
45. Chen XP, Du GH. Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin Med J (Engl) 2007; 120: 421-426
46. Mango R, Clementi F, Borgiani P, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003; 40: 933-936 (Pubitemid 38117545)
47. Chen XP DG. Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin Med J (Engl) 2007; 120: 421-426
48. Ohmori R, Momiyama Y, Nagano M, et al. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 2004; 27: 641-644 (Pubitemid 39441747)
49. Trabetti E, Biscuola M, Cavallari U, et al. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 2006; 14: 127-130 (Pubitemid 43019094)
50. Ye S, Gale CR, Martyn CN. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 2003; 24: 1668-1671 (Pubitemid 37174907)
51. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58: 5321-5325 (Pubitemid 28551108)
52. Nojiri T, Morita H, Imai Y, et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 2003; 92: 181-186 (Pubitemid 37509980)
53. Horne BD, Camp NJ, Carlquist JF, et al. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J 2007; 154: 751-758 (Pubitemid 47429598)
54. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 2003; 41: 2130-2137 (Pubitemid 36724257)